Biblio print

Tree Display

AceDB Schema

XML Display


Paper(s) concerning Trelagliptin

7 reference(s) found.
Listing paper details in reverse chronological order.
We are grateful to Keith Bradnam for improvment of this script

    Title: Trelagliptin ameliorates IL-1beta-impaired chondrocyte function via the AMPK/SOX-9 pathway
    Liu J, Zuo Q, Li Z, Chen J, Liu F
    Ref: Mol Immunol, 140:70, 2021 : PubMed


    Title: Safety evaluation of trelagliptin in the treatment of Japanese type 2 diabetes mellitus patients
    Kaku K
    Ref: Expert Opin Drug Safety, 16:1313, 2017 : PubMed


    Title: Trelagliptin (SYR-472, Zafatek), Novel Once-Weekly Treatment for Type 2 Diabetes, Inhibits Dipeptidyl Peptidase-4 (DPP-4) via a Non-Covalent Mechanism
    Grimshaw CE, Jennings A, Kamran R, Ueno H, Nishigaki N, Kosaka T, Tani A, Sano H, Kinugawa Y and Takeuchi K <2 more author(s)>
    Ref: PLoS ONE, 11:e0157509, 2016 : PubMed


    Title: Effect of trelagliptin on vascular endothelial functions and serum adiponectin level in patients with type 2 diabetes: a preliminary single-arm prospective pilot study
    Ida S, Murata K, Betou K, Kobayashi C, Ishihara Y, Imataka K, Uchida A, Monguchi K, Kaneko R and Takahashi H <1 more author(s)>
    Ref: Cardiovasc Diabetol, 15:153, 2016 : PubMed


    Title: First novel once-weekly DPP-4 inhibitor, trelagliptin, for the treatment of type 2 diabetes mellitus
    Kaku K
    Ref: Expert Opin Pharmacother, 16:2539, 2015 : PubMed


    Title: Trelagliptin: First Global Approval
    McKeage K
    Ref: Drugs, 75:1161, 2015 : PubMed


    Title: SYR-472, a novel once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor, in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial
    Inagaki N, Onouchi H, Sano H, Funao N, Kuroda S, Kaku K
    Ref: Lancet Diabetes Endocrinol, 2:125, 2014 : PubMed


Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page

Acknowledgements and disclaimer